Related references
Note: Only part of the references are listed.Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
Gina Song et al.
CLINICAL CANCER RESEARCH (2014)
A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma
Michiel Kroesen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Animal Models and the Tumor Microenvironment: Studies of Tumor-Host Symbiosis
Daniel Lindner
SEMINARS IN ONCOLOGY (2014)
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma
Lena-Maria Carlson et al.
CARCINOGENESIS (2013)
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
Michel DuPage et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities
Douglas W. McMillin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
High-Throughput Molecular and Histopathologic Profiling of Tumor Tissue in a Novel Transplantable Model of Murine Neuroblastoma: New Tools for Pediatric Drug Discovery
Jimmy K. Stauffer et al.
CANCER INVESTIGATION (2012)
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
Moniek Heusinkveld et al.
JOURNAL OF IMMUNOLOGY (2011)
Defining the critical hurdles in cancer immunotherapy
Bernard A. Fox et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
Tal Teitz et al.
PLOS ONE (2011)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma
W. Maes et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo
Qiang Zhou et al.
JOURNAL OF IMMUNOLOGY (2008)
Cell lines from MYCN transgenic murine turnours reflect the molecular and biological characteristics of human neuroblastorna
Andy J. Cheng et al.
EUROPEAN JOURNAL OF CANCER (2007)
Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
JK Stauffer et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages
MC Bibby
EUROPEAN JOURNAL OF CANCER (2004)
Mechanisms of embryonal tumor initiation:: Distinct roles for MycN expression and MYCN amplification
LM Hansford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
